K. Gabrysch

Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study

A. Siegbahn, L. Wallentin, S. James, 2020, Thrombosis and Haemostasis.

Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study

C. Held, C. Cannon, K. Mahaffey, 2018, JAMA cardiology.

Does the Alpha-defensin Immunoassay or the Lateral Flow Test Have Better Diagnostic Value for Periprosthetic Joint Infection? A Systematic Review

N. Hailer, S. Lazarinis, Hannah K Eriksson, 2018, Clinical orthopaedics and related research.

Antibodies against MYC-Associated Zinc Finger Protein: An Independent Marker in Acute Coronary Syndrome?

L. Wallentin, R. Schmidt, T. Witte, 2017, Front. Immunol..

Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy

A. Siegbahn, L. Wallentin, S. James, 2018, European heart journal.

AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

C. Lindskog, N. Eriksson, J. Wiśniewski, 2022, Clinical and translational gastroenterology.

Erratum to: Does the Alpha-defensin Immunoassay or the Lateral Flow Test Have Better Diagnostic Value for Periprosthetic Joint Infection? A Systematic Review.

N. Hailer, S. Lazarinis, Hannah K Eriksson, 2018, Clinical orthopaedics and related research.